The drug development process includes several phases, starting with preclinical testing on animals and moving to clinical trials on humans. These trials are divided into three phases: - Phase I: Tests for safety and dosage on a small group of healthy volunteers. - Phase II: Explores efficacy and side effects on a larger group of patients. - Phase III: Confirms effectiveness, monitors side effects, and compares the drug to commonly used treatments in a larger patient population.
